Huifeng Bio-Pharmaceutical Technology signed a Letter of Intent under which it will assume operational control of Xi'an Qinba Xintong Medical Ltd. in exchange for a management fee that equals all of Qinba’s profit. Huifeng manufactures plant extracts and pharmaceutical raw materials, while Qinba is focused on finished medical devices. Huifeng is interested in the deal because of Qinba's relationships with customers.  More details...

Stock Symbol: (OTCBB: HFGB)